Where are we with stem cell therapies in 2018?
We have a long way to go before we can do more than identify and trust in the black box of stem cells
We have a long way to go before we can do more than identify and trust in the black box of stem cells
These four 79yo men don’t have any way to know what their lives would have been like without taking adaptogens.
We quantify over 500 markers distributed across your genome to precisely quantify your biological age
Dying young but with perfect babies is sustainable and advantaged; dying old but with abnormal babies is an evolutionary dead end.
I wrote a book encouraging people to increase their telomerase activity. So did a Nobel Prize winner. I recommend getting help with telomerase activators. She did not.
Failure to faithfully replicate and preserve stem cell DNA appears to be the final common pathway to premature aging
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness